Catalog |
name |
Description |
price |
R-R-1672 |
Tauroursodeoxycholate-d4 sodium CAS No.2410279-95-5 |
Tauroursodeoxycholate-d4 (sodium)/CAS No.2410279-95-5 is the deuterium labeled Tauroursodeoxycholate sodium. Tauroursodeoxycholate (Tauroursodeoxycholic acid; TUDCA) sodium is an endoplasmic reticulum (ER) stress inhibitor. Tauroursodeoxycholate significantly reduces expression of apoptosis molecules, such as caspase-3 and caspase-12. Tauroursodeoxycholate also inhibits ERK. |
price> |
R-R-1673 |
Taurochenodeoxycholic acid-d4 sodium CAS No.2410279-85-3 |
Taurochenodeoxycholic acid-d4 (sodium)/CAS No.2410279-85-3 is the deuterium labeled Taurochenodeoxycholic acid. Taurochenodeoxycholic acid (12-Deoxycholyltaurine) is one of the main bioactive substances of animals bile acid. Taurochenodeoxycholic acid induces apoptosis and shows obvious anti-inflammatory and immune regulation properties. |
price> |
R-R-1674 |
Xanthoangelol CAS No.62949-76-2 |
Xanthoangelol/CAS No.62949-76-2, extracted from Angelica keiskei, suppresses obesity-induced inflammatory responses. Xanthoangelol possesses antibacterial activity. Xanthoangelol inhibits monoamine oxidases. Xanthoangelol induces apoptosis in neuroblastoma and leukemia cells. |
price> |
R-R-1675 |
Flavokawain A CAS No.3420-72-2 |
Flavokawain A/CAS No.3420-72-2, a proming anticarcinogenic agent, is a chalcone from kava extract with anti-tumor activity. Flavokawain A induces cell apoptosis by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway. Flavokawain A has the potential for the study of bladder cancer. |
price> |
R-R-1676 |
Soyasapogenol A CAS No.508-01-0 |
Soyasapogenol A/CAS No.508-01-0, a triterpene compound, isolated from soybean. Soyasapogenol A directly prevents apoptosis of hepatocytes, and secondly, inhibits the elevation of plasma TNF-α, which consequently results in the prevention of liver damage in the Concanavalin A-induced hepatitis model. |
price> |
R-R-1677 |
OSU-T315 CAS No.2070015-22-2 |
OSU-T315 (ILK-IN-1)/CAS No.2070015-22-2 is a small Integrin-linked kinase (ILK) inhibitor with an IC50 of 0.6 μM, inhibiting PI3K/AKT signaling by dephosphorylation of AKT-Ser473 and other ILK targets (GSK-3β and myosin light chain). OSU-T315 abrogates AKT activation by impeding AKT localization in lipid rafts and triggers caspase-dependent apoptosis in an ILK-independent manner. OSU-T315 causes cell death through apoptosis and autophagy. |
price> |
R-R-1678 |
Hellebrigenin CAS No.465-90-7 |
Hellebrigenin/CAS No.465-90-7, one of bufadienolides belonging to cardioactive steroids, is isolated from traditional Chinese medicine Venenum Bufonis. Hellebrigenin induces DNA damage and cell cycle G2/M arrest. Hellebrigenin triggers mitochondria-mediated apoptosis. |
price> |
R-R-1679 |
MTR-106 CAS No.1639357-93-9 |
MTR-106/CAS No.1639357-93-9 is a potent and orally active G-quadruplex stabilizer and RNA polymerase I inhibitor. MTR-106 induces apoptosis and inhibits cell growth. MTR-106 can be used in research of cancer. |
price> |
R-R-1680 |
Dehydroeffusol CAS No.137319-34-7 |
Dehydroeffusol/CAS No.137319-34-7 is a phenanthrene from medicinal herb Juncus effuses. Dehydroeffusol inhibits gastric cancer cell growth and tumorigenicity by selectively inducing tumor-suppressive endoplasmic reticulum stress and a moderate apoptosis. It shows very low toxicity. |
price> |
R-R-1681 |
Tauroursodeoxycholate-d4 CAS No.2410279-94-4 |
Tauroursodeoxycholate-d4/CAS No.2410279-94-4 is deuterium labeled Tauroursodeoxycholate. Tauroursodeoxycholate (Tauroursodeoxycholic acid) is an endoplasmic reticulum (ER) stress inhibitor. Tauroursodeoxycholate significantly reduces expression of apoptosis molecules, such as caspase-3 and caspase-12. Tauroursodeoxycholate also inhibits ERK. |
price> |